TY  - CONF

T1  - Abstract CT123: A randomised phase 2 study of paclitaxel with or without trametinib or pazopanib in advanced wild type BRAF melanoma

JO  - Cancer Research

UR  - https://doi.org/10.1158/1538-7445.am2017-ct123

PY  - 2017/07/01

AU  - Middleton MR

AU  - Schadendorf D

AU  - Danson S

AU  - Marshall E

AU  - Corrie P

AU  - Love SB

AU  - Mohammed SB

AU  - Scudder C

AU  - Goff M

ED  - 

DO  - DOI: 10.1158/1538-7445.am2017-ct123

PB  - American Association for Cancer Research (AACR)

VL  - 77

IS  - 13_Supplement

SP  - CT123

EP  - CT123

Y2  - 2025/12/07

ER  -